Blocking Alpha(4)Beta(2) And Alpha(7) Nicotinic Acetylcholine Receptors Inhibits The Reinstatement Of Morphine-Induced Cpp By Drug Priming In Mice

Bin Feng,Jiang-Hao Xing,Dong Jia,Shui-Bing Liu,Hong-Ju Guo,Xiao-Qiang Li,Xiao-Sheng He,Ming-Gao Zhao
DOI: https://doi.org/10.1016/j.bbr.2011.01.040
IF: 3.352
2011-01-01
Behavioural Brain Research
Abstract:Investigating the interaction between nicotinic and opioid receptors is of great interest for both basic mechanistic and clinical reasons. Morphine and nicotine, two common drugs of abuse, share several behavioral and rewarding properties. However, little is known about the subtypes of nicotinic acetylcholine receptors (nAChR) in the reinstatement of morphine-induced conditioned place preference (CPP). In this study, we found that a non-specific nAChR agonist, nicotine (0.5 mg/kg), had no effects on the reinstatement of morphine-induced CPP. However, we found that pretreatment with specific alpha(4)beta(2) and alpha(7) nAChR subtype antagonists, dihydroxy-beta-erithroidine (DH beta E, 5 mg/kg) and methyllycaconitine (MLA, 4 mg/kg), 20 min prior to administration of morphine, inhibited the reinstatement of morphine-induced CPP by drug priming in mice. Furthermore, depression of the reinstatement of morphine-induced CPP by a single DH beta E or MLA treatment lasted at least three days later when the reinstatement was induced by morphine priming. The data suggest that specific nAChR subtypes, i.e., alpha(4)beta(2) and alpha(7), may contribute to the reinstatement of morphine-induced CPP by drug priming in mice. (C) 2011 Elsevier B.V. All rights reserved.
What problem does this paper attempt to address?